AEON Biopharma, Inc. Cash and Restricted Cash
AEON Biopharma, Inc. (AEON) had Cash and Restricted Cash of $3.43 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.43M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.24M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.01M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.93M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $3.43M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $6.24M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $3.01M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $5.93M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $8.44M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $10.45M 10-Q · filed 2026-05-14 | |
| 2024-12-31 | $13.00K 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $537.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $3.44M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $1.56M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $5.16M 10-K · filed 2026-03-30 | |
| 2023-06-30 | $2.60M 10-Q · filed 2024-08-12 | $441.38K 10-Q · filed 2023-07-21 |
| 2023-03-31 | $4.69M 10-Q · filed 2024-05-14 | $457.08K 10-Q · filed 2023-05-17 |
| 2022-12-31 | $9.75M 10-Q · filed 2024-08-12 | $67.91K 10-K · filed 2023-02-22 |
| 2022-09-30 | $22.20M 10-Q · filed 2023-11-13 | $27.76K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.76K 10-Q · filed 2023-07-21 | |
| 2022-03-31 | $166.24K 10-Q · filed 2023-05-17 | |
| 2021-12-31 | $5.13M 10-K/A · filed 2024-05-14 | $497.41K 10-K · filed 2022-03-28 |
| 2021-09-30 | $663.54K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $988.86K 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $1.44M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $0.00 10-Q/A · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |